330 related articles for article (PubMed ID: 27343615)
21. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
22. Systematic comparison of sensitivity between hydrophilic interaction liquid chromatography and reversed phase liquid chromatography coupled with mass spectrometry.
Periat A; Boccard J; Veuthey JL; Rudaz S; Guillarme D
J Chromatogr A; 2013 Oct; 1312():49-57. PubMed ID: 24034137
[TBL] [Abstract][Full Text] [Related]
23. Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies.
Spagou K; Tsoukali H; Raikos N; Gika H; Wilson ID; Theodoridis G
J Sep Sci; 2010 Mar; 33(6-7):716-27. PubMed ID: 20187037
[TBL] [Abstract][Full Text] [Related]
24. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
Huang Z; Lin L; Gao Y; Chen Y; Yan X; Xing J; Hang W
Mol Cell Proteomics; 2011 Oct; 10(10):M111.007922. PubMed ID: 21799048
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics.
Cui Y; Liu X; Wang M; Liu L; Sun X; Ma L; Xie W; Wang C; Tang S; Wang D; Wu Q
J Neuropathol Exp Neurol; 2014 Oct; 73(10):954-63. PubMed ID: 25192049
[TBL] [Abstract][Full Text] [Related]
26. Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism.
Ivanisevic J; Zhu ZJ; Plate L; Tautenhahn R; Chen S; O'Brien PJ; Johnson CH; Marletta MA; Patti GJ; Siuzdak G
Anal Chem; 2013 Jul; 85(14):6876-84. PubMed ID: 23781873
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
Zhang T; Watson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
[TBL] [Abstract][Full Text] [Related]
28. Untargeted metabolomics of bladder tissue using liquid chromatography and quadrupole time-of-flight mass spectrometry for cancer biomarker detection.
Nizioł J; Ossoliński K; Płaza-Altamer A; Kołodziej A; Ossolińska A; Ossoliński T; Krupa Z; Ruman T
J Pharm Biomed Anal; 2024 Mar; 240():115966. PubMed ID: 38217999
[TBL] [Abstract][Full Text] [Related]
29. A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan.
Wu X; Huang Y; Sun J; Wen Y; Qin F; Zhao L; Xiong Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():40-49. PubMed ID: 29132024
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
32. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
[TBL] [Abstract][Full Text] [Related]
33. Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics--a pilot study.
Zhang X; Choi FF; Zhou Y; Leung FP; Tan S; Lin S; Xu H; Jia W; Sung JJ; Cai Z; Bian Z
FEBS J; 2012 Jul; 279(13):2322-38. PubMed ID: 22520047
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the performance of sample preparation methods for ultra-performance liquid chromatography/mass spectrometry based serum metabonomics.
Chan W; Zhao Y; Zhang J
Rapid Commun Mass Spectrom; 2019 Mar; 33(6):561-568. PubMed ID: 30614103
[TBL] [Abstract][Full Text] [Related]
35. Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system.
Yang Q; Shi X; Wang Y; Wang W; He H; Lu X; Xu G
J Sep Sci; 2010 Jun; 33(10):1495-503. PubMed ID: 20309903
[TBL] [Abstract][Full Text] [Related]
36. Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the quantification of ephedrines using medium-resolution accurate mass spectrometry.
Gray N; Heaton J; Musenga A; Cowan DA; Plumb RS; Smith NW
J Chromatogr A; 2013 May; 1289():37-46. PubMed ID: 23570855
[TBL] [Abstract][Full Text] [Related]
37. Metabonomics study of brain-specific human S100B transgenic mice by using high-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry.
Liu JL; Wang HL; Zhang LF; Xu YF; Deng W; Zhu H; Qin C
Biol Pharm Bull; 2011; 34(6):871-6. PubMed ID: 21628886
[TBL] [Abstract][Full Text] [Related]
38. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS.
Chen J; Hou H; Chen H; Luo Y; Zhang L; Zhang Y; Liu H; Zhang F; Liu Y; Wang A; Hu Q
J Pharm Biomed Anal; 2019 Apr; 167():83-89. PubMed ID: 30759408
[TBL] [Abstract][Full Text] [Related]
39. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
40. Tissue Multiplatform-Based Metabolomics/Metabonomics for Enhanced Metabolome Coverage.
Vorkas PA; Abellona U MR; Li JV
Methods Mol Biol; 2018; 1738():239-260. PubMed ID: 29654595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
